somatic mutations as markers of outcome after azacitidine and allogenic stem cell transplantation in higher risk myelodysplastic syndromes

Research output: Contribution to journal › Article

Fingerprint

Dive into the research topics of 'somatic mutations as markers of outcome after azacitidine and allogenic stem cell transplantation in higher risk myelodysplastic syndromes'. Together they form a unique fingerprint.

Medicine & Life Sciences